The Centre for Personalised Medicine was established in April 2017 following an award of €8.6 million from the EU’s INTERREG VA Programme and managed by the Special EU Programmes Body (www.SEUPB.eu) This cross-border collaborative project, led by Stratified Medicine Ulster University includes 13 partner organisations.
The Centre for Personalised Medicine’s five Research Clusters use the methods and technologies from personalised medicine and apply them to heart disease, emergency surgery, acute kidney injury, unscheduled care in diabetes and diagnostic accuracy in dementia. These are areas associated with significant clinical need and commercial potential and will benefit significantly from the interdisciplinary academic and commercial cross-border expertise and collaboration.
Objectives of the Centre for Personalised Medicine
- Improve the triage of patients with chest pain to allow more appropriate and rapid emergency referral for Primary Coronary Intervention
- Identify determinants of outcomes in emergency surgery to improve care pathways and reduce morbidity and mortality
- Earlier recognition of Acute Kidney Injury to reduce mortality, morbidity and hospital stay
- Improve the self-management of diabetes to reduce unscheduled care episodes and hospital admissions
- Develop tools which will allow earlier diagnosis of dementia and therefore earlier clinical intervention and support
- Western Health and Social Care Trust
- Letterkenny University Hospital
- Letterkenny Institute of Technology
- University of the Highlands and Islands
- NHS Highlands
- Randox Laboratories and Randox Teoranta
- United Health Group / Optum
- Voscuris Ltd..
- Healthcare Analytics Ltd.
- Northern Ireland Clinical Research Services Ltd.
- National university of Ireland Galway
- Donegal Clinical Research Academy
- Clinical Translational Research and Innovation Centre
This project is supported by the European Union's INTERREG VA Programme, managed by the Special EU Programmes Body (SEUPB).